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This is the first in a series of articles highlighting the delivery of
‘‘packages of care’’ for mental health disorders in low- and middle-
income countries. Packages of care are combinations of treatments aimed
at improving the recognition and management of conditions to achieve
optimal outcomes.
Introduction
Depression is the leading cause of disease burden in most
regions of the world [1]. The International Classification of
Disease (ICD) 10 diagnostic criteria for depressive episode are
shown in Box 1. Somatic presentations are very common,
especially tiredness, sleep problems, and aches and pains. Of
these, only tiredness is considered a ‘‘core’’ feature in current
classifications. Anxiety symptoms often coexist with depressive
symptoms, particularly in community or primary care samples.
The term ‘‘common mental disorders’’ is used to describe the
heterogeneous presentation of anxiety, depressive, and somatic
symptoms in these contexts [2].
The World Mental Health Surveys have described the
prevalence and help-seeking behaviours of people with depression
in a large number of countries [3,4]. The major observations
about the epidemiology of depression from these and other studies
on depression can be summarized as follows: (1) the constellation
of symptoms used to characterize depression can be identified in
all cultures; (2) the prevalence rates of depression vary consider-
ably between populations, with rates ranging from about 6% in
China to over 20% in the US; (3) the age of onset is most
commonly in young adulthood; (4) the disorder often runs a
relapsing or chronic course; (5) the disorder is two to three times
more common in women, although a few studies, particularly from
Africa, have not shown this female excess; and (6) social factors,
particularly related to economic or social disadvantages such as
low education and violence, are major determinants of the risk for
depression [5].
Depression is the leading neuropsychiatric cause of the burden
of disease globally and in low- and middle-income countries
(LMIC), and is projected to be, overall, the second leading cause of
burden of disease by 2020 [6,7]. Apart from its profound impact
on function, depression is associated with increased mortality
(particularly through suicide). The condition is often comorbid
with other chronic diseases such as diabetes and is responsible for a
significant proportion of the disability associated with these
conditions [8]. Depression has been associated with a range of
poor health outcomes, including poor infant growth (in the case of
maternal depression in some countries in South Asia, for example)
and worse physical health (for example, cardiovascular or HIV
outcomes through poor adherence) [9,10].
In this article we focus on the effective management of
depression in LMICs, reviewing the evidence on efficacy of
treatments and delivery of interventions derived from LMICs to
the extent possible. Because that evidence is often limited, we also
cite systematic reviews or meta-analyses based on global evidence
and key trials from high income countries (HIC) where
appropriate. On the basis of our review we propose a package
of care—a combination of treatments aimed at improving the
recognition and management of conditions to achieve optimal
outcomes—for depression.
The Evidence on the Treatment of Depression
Detection of Depression
A critical first step in the provision of treatments for any
disorder is its effective recognition (Table 1). An extensive
literature has examined the validity of depression severity
measures in HICs. A systematic review [11] examined the
accuracy of several commonly used measures including the Beck
Depression Inventory (BDI), the Center for Epidemiologic Studies
Depression Scale (CES-D), the Zung Self-Rated Depression Scale
(SDS), and the Hopkins Symptom Checklist (HSCL). That review
found that all commonly used measures performed well in
identifying depression among primary care patients, and no
measure was recommended over others. The Patient Health
Questionnaire (PHQ) was specifically designed to identify and
monitor depression severity among primary care patients.
Considerable research in the US and Western Europe supports
its validity [12,13].
A relatively large body of research has examined the validity
of depression case-finding measures among primary care
patients and community residents, and this body of work has
focused on measures with more international lineage including
the General Health Questionnaire (GHQ), the Self-Reporting
Questionnaire (SRQ), and the Kessler Distress Scale (K6).
Studies focused on these measures have been done in LMICs
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including India [14], Ethiopia [15], Burkina Faso [16], Chile
[17–19], Brazil [20,21], Mongolia [22], as well as the 15-site
World Health Organization Collaborative study [23], and
support the validity of each of these measures in primary care
and community settings.
Drug Therapies
Given requirements for drug licensure in the US and Western
Europe, a large research literature examines the efficacy of
antidepressants in HICs. In its original guidelines for depression
treatment in primary care [24], the US Agency for Healthcare
Policy and Research summarized data regarding older antide-
pressants, with an emphasis on studies conducted in primary care
settings. That meta-analysis found strong evidence for the efficacy
of antidepressant pharmacotherapy and no evidence of advantage
for any specific drug over any other. Two subsequent meta-
analyses [25,26] reached a similar conclusion regarding newer
antidepressant drugs.
However, one recent meta-analysis found that differences do
exist between various newer antidepressants with sertraline
emerging as the drug of choice on the basis of superior efficacy
and acceptability and lower cost [27]. Furthermore, there is
evidence of the greater tolerability of selective serotonin reuptake
inhibitors (SSRIs) over tricyclic antidepressants [28], and, for the
treatment of depression in adolescents, fluoxetine has been
identified as the antidepressant with the optimal balance of benefit
versus harm [29].
Following a therapeutic response, antidepressant continuation
treatment for a period of 9 to 12 mo has been found to
significantly reduce the risk of relapse/recurrence [30].
Conversely, there are some studies that refute the efficacy of
antidepressants in the treatment of depression, attributing the
perceived effect to publication bias [31] or to the decreased
responsiveness to placebo in severely depressed patients (rather
than increased responsiveness to antidepressants) [32]. These
findings have led to some investigators recommending the need to
enhance transparent reporting of clinical trials and reinvigorate
antidepressant drug discovery [33].
The literature supporting the efficacy of antidepressant
pharmacotherapies for primary care patients in LMICs is
relatively small. A randomized trial in India found fluoxetine
superior to placebo (specifically at 2-mo follow up) among primary
care patients with raised levels of psychological distress [34]. In
two Chilean studies [35,36],which evaluated stepped care,
including antidepressants, for women with depression, significant
improvements were seen at 6 mo in the intervention group
compared to the control group (70% versus 30% in one study and
34% versus 9% in the other study). Although we are not aware of
any evidence that medications proven efficacious in HICs are
ineffective in other settings, there is some evidence of interethnic
differences in the dosing requirements of antidepressant medica-
tion that may be attributable to pharmacogenetic polymorphism
[37,38]. This observation may have important implications for
Table 1. The evidence in support of depression treatment.
Depression Treatment Evidence from HICs Evidence from LMICs
Detection and monitoring Meta-analysis of sensitivity and specificity for nine screening
measures including BDI, CES-D, SDS, and HSCL [11]
Sensitivity and specificity of two-item PHQ depression screener [12]
Meta-analysis of accuracy of nine-item PHQ depression scale [13]
GHQ, K6, and SRQ in primary care in India [14]
SRQ for perinatal pression in Ethiopia [15]
K6 for postnatal depression in Burkina Faso [16]
SRQ for women of childbearing age in Mongolia [22]
GHQ in 15-site primary care study [23]
HSCL in pregnant women positive for HIV in Tanzania [59]
GHQ and SRQ in primary care in Chile and in Brazil [17,18,20,21]
CIS-R in the community setting in Chile [19]
Antidepressant pharmacotherapy Meta-analysis of efficacy for older antidepressants [24]
Meta-analysis of efficacy for newer antidepressants [25]
RCT of fluoxetine in Indian primary care patients [75]
Cognitive-behavioural therapy
(CBT)
Meta-analyses of efficacy of CBT for depression [39,40] RCT of CBT delivered by community health workers for
perinatal depression in Pakistan [46]
RCT of group CBT for depressed primary care patients in Chile
[35]
Interpersonal therapy (IPT) Systematic review of efficacy of IPT for depression [41] RCT of group interpersonal psychotherapy [47,48]
Problem-solving therapy (PST) Meta-analysis of efficacy of PST for depression [44] —
Electroconvulsive therapy (ECT) Meta-analysis of efficacy of ECT for depression [50] —
Abbreviations: BDI, Beck Depression Inventory; CES-D, Center for Epidemiologic Studies Depression Scale; CIS-R, Revised Clinical Interview Schedule for Depression;
GHQ, General Health Questionnaire; HSCL, Hopkins Symptom Checklist; K6, Kessler Distress Scale; PHQ, Patient Health Questionnaire; SDS, Zung Self-Rated Depression
Scale; SRQ, Self-Reporting Questionnaire.
doi:10.1371/journal.pmed.1000159.t001
Box 1. International Classification of Disease
10 Criteria for Depressive Episode
F 32: Depressive Episode. In typical mild, moderate, or
severe depressive episodes, the patient suffers from
lowering of mood, reduction of energy, and decrease in
activity. Capacity for enjoyment, interest, and concentra-
tion is reduced, and marked tiredness after even minimum
effort is common. Sleep is usually disturbed and appetite
diminished. Self-esteem and self-confidence are almost
always reduced and, even in the mild form, some ideas of
guilt or worthlessness are often present. The lowered
mood varies little from day to day, is unresponsive to
circumstances and may be accompanied by so-called
‘‘somatic’’ symptoms, such as loss of interest and
pleasurable feelings, waking in the morning several hours
before the usual time, depression worst in the morning,
marked psychomotor retardation, agitation, loss of appe-
tite, weight loss, and loss of libido. Depending upon the
number and severity of the symptoms, a depressive
episode may be specified as mild, moderate or severe.
Source: World Health Organization [74].
PLoS Medicine | www.plosmedicine.org 2 October 2009 | Volume 6 | Issue 10 | e1000159
drug side effects and adherence to antidepressant medication, and
is an important area of future study.
Structured Psychotherapies
Several randomized trials from HICs support the efficacy of
depression-specific structured psychotherapies. Meta-analyses
[39,40] found strong evidence that cognitive therapy for
depression is superior to no treatment or a wait-list control
condition and some evidence that it is superior to other
unstructured or nonspecific psychotherapies. A systematic review
[41] found consistent evidence for the efficacy of interpersonal
psychotherapy among depressed outpatients.
Most trials of cognitive therapy and interpersonal psychother-
apy have been conducted in specialty mental health clinics. In
primary care settings, there is consistent evidence favouring brief
psychological treatments over treatment as usual [42]. In addition,
behavioural activation has been found to be effective in reducing
depressive symptoms and is said to be a relatively simple and
potentially feasible form of psychological treatment in nonspecia-
lised health care settings [43]. A meta-analysis [44] found that
problem-solving therapy had a strong therapeutic effect, but that
this effect varied considerably between studies. Most trials of
problem-solving therapy have been conducted in primary care
settings. A separate meta-analysis by Cuijpers and colleagues [45]
compared all of these structured therapies, finding no evidence
that one was superior to any other although they were reported to
be superior to nonspecific supportive therapy.
As for the evidence from LMICs, several randomized trials have
evaluated the effectiveness of structured psychotherapy programs,
mostly comparing adapted psychotherapy programs to usual care
or no-treatment control conditions. A randomized trial in Pakistan
by Rahman and colleagues showed the effectiveness of a cognitive-
behavioural therapy delivered by community health workers [46].
Two trials in Chile [35,36] found a benefit from stepped-care
depression treatment, based upon a structured group cognitive-
behavioural therapy program, for women presenting to primary
care clinics. Two trials from Uganda showed the effectiveness of
group interpersonal psychotherapy for depressed residents of rural
villages [47] and among depressed adolescents residing in refugee
camps [48]. One primary care-based trial in India found no
benefit of problem-solving therapy [34]; poor adherence and the
high prevalence of severe psychosocial stressors were said to be
possible reasons for this poor response [49].
Electroconvulsive Therapy
A recent meta-analysis of the efficacy of electroconvulsive therapy
(ECT) in depression reported a significant benefit of ECT over
antidepressants, placebo, and simulated ECT particularly for severe
and resistant forms [50]. This review consisted of evidence from
randomized and nonrandomized controlled trials mostly from
HICs. Additionally, ECT has been argued to be the treatment of
choice for severe depression in late life [51]. However, a prospective
naturalistic study found that the rate of remission of depression with
ECT in community settings is substantially less than that reported in
clinical trials [52]. There are no recent studies of ECT efficacy in
LMICs where the practice of ECT may in fact be suboptimal due to
poor provider methods such as use of bilateral electrode placement,
use of sine wave ECT, lack of EEG monitoring, and in some cases,
use of unmodified ECT [53].
Delivery of Effective Interventions
Depression screening and outcome questionnaires appear to
perform well across a wide range of settings. Conventional
depression treatments, including medications, structured psycho-
therapies, and ECT appear to have therapeutic benefits.
Although the evidence base for the efficacy of depression
treatments is not large in LMICs, the evidence we reviewed
suggests that depression treatments are just as effective in more
disadvantaged patient populations or under-resourced systems of
care. All treatments seem to achieve about the same degree of
benefit, with combination treatments (both medication and
psychotherapy, and ECT for selected individuals), having greater
effect in more severe or monotherapy-resistant cases.
Interventions to Increase Demand for Services
Stigma and the lack of awareness of mental disorders lead to the
under-use of available mental health services (Table 2). In HICs
awareness campaigns for depression have sought to address this
problem by targeting the public, medical professionals, and
educational institutions [54,55]. In LMICs we found one study
that aimed to increase community awareness of mental health
problems by implementing a school mental health program [56].
The 4-mo program of mental health education in rural Pakistan
was conducted by a team of experts in collaboration with teachers
and schoolchildren. The program led to a significant improvement
in mental health awareness among students and, through them,
other members of the local community. However, the impact of
this intervention on increasing demand for services was not
reported.
Interventions to Improve Capacity of Health Care Teams
A recent report by the World Health Organisation (WHO) and
the World Organisation of Family Doctors (WONCA) on
integrating mental health into primary care reviewed training
initiatives in different settings [57]. Two examples are described
here.
The program in Sembabule, Uganda consisted of specialist
outreach services from the hospital to the primary care level
providing training and ongoing mentoring of primary care workers
to provide mental health services. The primary care workers were
trained to identify mental health problems, treat patients with
uncomplicated common mental disorders, and provide emergency
care and referral services. In-service training of general health
workers was found to be especially challenging because of
understaffing and hence increased workload resulting from added
mental health tasks. This training was complemented by the
formation of village health teams consisting of trained volunteers.
The formation of these teams turned out to be a key step in the
mental health integration process.
A mental health program in Kerala, India faced the added
challenge of the transfer of trained health workers from the
participating clinics to new locations at regular intervals as
mandated by government regulations. Thus, frequent ongoing
training of newly arrived health workers led to an added burden
on resources. Additionally, for the treatment of a chronic
condition such as depression, training alone is ineffective and
adequate specialist supervision is a vital component of any training
initiative.
Interventions to Improve the Recognition of Depression
There is evidence that locally validated screening instruments
can be used by nonphysician and community health workers.
When used in such settings, these instruments have comparable
psychometric properties and clinical utility to one another. When
systematically adapted for use in the local context, such
instruments show good criterion validity against both biomedical
diagnostic criteria and local descriptions of depression. One such
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example is the HSCL. When compared with a locally described
syndrome approximating depression derived from ethnographic
research, this instrument had a sensitivity of 95% [58], Further,
HSCL-25 and its depression subscale the HSCL-15, both had
sensitivities of 89% for detection of Diagnostic and Statistical
Manual of Mental Disorders, 4th edition (DSM-IV) major
depression with specificities of 80% and 79%, respectively [59].
A comparison of five screening questionnaires in a primary care
setting in India, administered by a school graduate with 1 wk of
training, found that they all had comparable case detection
psychometric properties [14].
A recent meta-analysis of studies from HICs suggested that
screening may not necessarily be the most efficient method for case
detection; it reported that intervention effect sizes were larger
when patients were referred by general practitioners (GPs) than
when referred through systematic screening [42]. A possible
explanation may be that those identified by GPs tend to have more
severe symptoms than those identified through screening. The
Improving Mood-Promoting Access to Collaborative Treatment
(IMPACT) study, which enrolled participants by screening and by
GP referrals but used the same entry criteria for both, found equal
benefit of the collaborative care intervention (involving a
collaboration between the primary care team and a supervising
psychiatrist) program in the two groups [60]. In any event,
although screening questionnaires are a useful tool in primary
care, given the variability in GP practice, they need to be
supplemented with clinical judgment.
Interventions to Increase the Acceptability and Reduce
the Costs of Treatments
According to the WHO/WONCA report [57], psychological
treatments such as interpersonal therapy and cognitive-behav-
ioural therapy have almost all been developed in HICs and need
to be adapted to be culturally relevant in LMICs. For example,
the Thinking Healthy Program, an adaptation of cognitive-
behavioural therapy, has been successfully adapted and used by
Lady Health Workers (women from local communities who are
trained to deliver basic health care interventions) in the
treatment of postnatal depression in Pakistan [46]. Adaptations
were made to render the therapy more acceptable, such as using
pictorial information to address low levels of literacy and
reducing the training period to address the time pressures for
the health workers. Providing psychological treatments in the
group setting builds on social mechanisms and networks that are
already in place in many nonwestern cultures. For example in
Uganda, a group interpersonal therapy program was based on
interpersonal triggers for depression and group relationship
building, concepts that were judged to be compatible with
Table 2. Delivering depression treatments.
Step How By Whom In What Settings
Increasing patient or consumer
demand
Improve mental health literacy
and reduce stigma [54–56]
Mental health specialists teams
[35,54–56,76]
Schools [56]
Public arena [54,55]
General practice, primary care [35,55]
Professional education institutions [54,55]
Increasing capacity of health care
teams
Training of primary care providers/
all health care providers (professional
and nonprofessional), including
support and supervision [57]
Mental health specialists team
[35,46–48,57]
Primary care, GPs, clinics, village health
teams [57]
Increasing recognition Community-based screening
Practice-based screening
Trained interviewers: high school
graduates [47]
School graduates with 1-wk training [14]
GPs
Community [47]
Primary care [14]
Antenatal clinic [77]
Adapting treatments to increase
acceptability or reduce cost
Integration of mental health services
with routine health care [57,61]
Provision of culturally acceptable care
[64,78,79]
Group psychotherapy interventions
[47,48]
Providing treatment in rural settings
[47]
Programs for vulnerable populations:
children [76] and poor women or
mothers [35,36,46]
Providing treatment in work settings [73]
Community health workers [35,46–48,64]
Locally trained paraprofessionals [76]
Rural community [46–48]
Primary care [35,36,64]
Schools: rural and those in violence
affected areas [56,76]
Practice-based programs to deliver
efficacious treatments
Collaborative care [62]
Stepped care [35,36]
Quality improvement programs [65,80]
Adherence support [66,81]
Case manager, specialist [62]
Nonmedical health worker [35,36]
Primary care [35,36,62,65,80]
Community-based programs to
deliver efficacious treatments
Group interventions [47,48,76]
Psychologically informed sessions: cognitive
behaviour, person-centred [68,78]
Web/telephone-based psychological
treatment [69]
Community health workers [47,48]
Health visitors [82]
Peer (mother to mother) support [69]
Former service users [69]
Community
Addressing impact of the disorder
on other health/social outcomes
Psychosocial stimulation [70,71]
Work-based programs [73,83]
Befriending to prevent suicide [72]
Paraprofessionals [71]
Case managers [73]
Community and practice based
doi:10.1371/journal.pmed.1000159.t002
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Ugandan culture, and was adapted for treatment of depression
both in adults in a rural community and in adolescent war
survivors [47,48]. Providing these treatments in the rural setting,
group setting, and using local community workers to deliver the
interventions appear also to be effective methods for reducing
costs of treatment [35,46,47,61].
Practice-Based Interventions to Deliver Efficacious
Treatments
Collaborative care models that incorporate systematic identifi-
cation of patients, active case management by competent staff, and
specialist supervision are effective for the integration of depression
treatment into primary care [62]. These models have largely been
developed in HICs. For example, the IMPACT trial successfully
used these principles in the treatment of late life depression in
primary care settings [60]. Here, intervention patients had access
to a case manager who offered education, care management,
antidepressant treatment support, and brief psychotherapy, all
done under the supervision of a psychiatrist and a primary care
expert. This treatment was significantly more effective than usual
care at the end of 12 mo. The model, however, may require
alteration in LMIC settings with few or no mental health
specialists; in such settings, other types of health practitioners
with appropriate training in mental health care may provide
leadership for the collaborative care program. A cluster random-
ized controlled trial of such a collaborative care model is currently
being conducted in India [63].
Another practice-based intervention may involve tailoring
depression treatment to match individual needs, which was the
principle behind the multicomponent stepped care intervention
used in primary care management of depression in Chile. Two
trials in this setting have produced amongst the highest recovery
rates recorded in any depression treatment studies and, notably,
did not involve a psychiatrist [35,36]. The intervention delivered
by a nonmedical health worker consisted of psychoeducational
groups, treatment adherence support, and pharmacotherapy for
those with severe depression. Commentators have noted that
stepped-care interventions for depression call for brief psychoed-
ucational interventions as first line treatment, reserving pharma-
cotherapy for those with more severe or treatment-resistant
depression [36,64].
In addition, practice-based quality improvement programs can
help improve delivery of efficacious treatments. These programs
have largely been developed in HICs to include strategies such as
institutional commitment, training of local leaders and health care
staff, and detection of depression. These measures can improve
both mental health and quality of care outcomes of primary care
depression programs [65]. Finally, a practice-based intervention to
improve adherence to medicines is periodic telephone contacts,
which was found to reinforce adherence to depression treatment in
women attending primary care in Chile [35,66].
Community-Based Interventions to Deliver Efficacious
Treatments
Evidence for community-based interventions to deliver mental
health care derives from both LMICs and HICs. A systematic
review of the effects of community-based models of mental health
care in LMICs found that these lead to improvement in mental
health outcomes and cost saving [67]. The study in rural Pakistan
cited earlier showed the effectiveness on maternal depression of
cognitive behavioural-based psychological intervention integrated
into the routine work of community-based primary level workers
[46]. A cluster randomized study conducted in urban and rural
areas of the Trent region in the UK showed the effectiveness of
training health visitors to detect postnatal depression and deliver
psychologically informed sessions in women’s homes [68].
Evidence suggests that advances in information and communi-
cation technology have increased the range of options available for
delivery of interventions in the community. Telephone counsel-
ling, for example, can increase accessibility, and is private and
nonstigmatising. In a trial in Ontario, Canada, telephone-based
support by former service users was found to be effective in women
identified as high risk for postnatal depression [69].
Interventions to Address other Health and Social
Outcomes
Other interventions to deliver efficacious mental health care
treatments include psychosocial stimulation programs [70,71] and
befriending to reduce suicide [72], which may have a role in
mitigating the effects of maternal depression on infant develop-
ment and of depression on suicidal behaviour. A US trial
incorporating depression screening, vigorous outreach, and care
management of depressed individuals improved not only clinical
outcomes but overall work functioning including job retention
[73].
Packages of Care for Depression
Depression is clearly a global health priority. Improving the
recognition of this disorder in clinical populations in LMICs is
aided by the successful adaption of depression-screening instru-
ments from HIC settings into settings with few resources and
weaker health systems. Our review suggests that evidence-based
treatments such as antidepressants and psychotherapy are effective
in managing depression; it is important, however, that such
treatments are adapted when used in LMICs to increase their
acceptability, accessibility, and manage their costs. We propose
two packages of care on the basis of the availability of mental
health specialist resources (Table 3). The delivery of these
treatments should ideally be carried out through an integration
of depression programs into existing health services or community
settings with task-shifting to nonspecialist health workers to deliver
front-line care and a supervisory framework of appropriately
skilled mental health workers.
Acknowledgment
We thank developmental editor Jane Bradbury.
Author Contributions
ICMJE criteria for authorship read and met: VP GS NC SK RA. Wrote
the first draft of the paper: VP. Contributed to the writing of the paper: VP
GS NC SK RA.
Table 3. Packages of care for depression.
Low Resourced Settings High Resourced Settings
Routine screening for
detection
High-risk or routine screening with confirmation
of diagnosis by skilled clinician
Psychoeducation Psychoeducation
Generic antidepressants Choice of antidepressants
Problem-solving Choice of brief psychological treatments
Electroconvulsive therapy
doi:10.1371/journal.pmed.1000159.t003
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